Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Miziara JE"'
2
Akademický článek
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.
Autor: Cavagna RO; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Escremim de Paula F; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Berardinelli GN; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Bonatelli M; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Santana I; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Albino da Silva EC; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Teixeira GR; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, Brazil., Zaniolo BG; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, Brazil., Mourão Dias J; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Ferreira da Silva FA; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Baston Silva CE; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Guimarães MGB; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Barone CP; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Jacinto AA; Deparment of Radiation Therapy, Barretos Cancer Hospital, Barretos, Brazil., Noleto da Nóbrega Oliveira RE; Deparment of Thoracic Surgery, Barretos Cancer Hospital, Barretos, Brazil., Miziara JE; Deparment of Thoracic Surgery, Barretos Cancer Hospital, Barretos, Brazil., De Marchi P; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Oncoclinicas, Rio de Janeiro, Brazil., Molina-Vila MA; Laboratory of Oncology/Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Publikováno v: The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. e1419-e1424.
Zobrazit plný text záznamu
3
Akademický článek
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
Autor: Cavagna RO; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Pinto IA; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Escremim de Paula F; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, São Paulo, Brazil., Berardinelli GN; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, São Paulo, Brazil., Sant'Anna D; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil., Santana I; Department of Pathology, Barretos Cancer Hospital, São Paulo, Brazil., da Silva VD; Department of Pathology, Barretos Cancer Hospital, São Paulo, Brazil., Da Silva ECA; Department of Pathology, Barretos Cancer Hospital, São Paulo, Brazil., Miziara JE; Department Thoracic Surgery, Barretos Cancer Hospital, São Paulo, Brazil.; Department of Medical Oncology, Barretos Cancer Hospital, São Paulo, Brazil., Mourão Dias J; Department of Medical Oncology, Barretos Cancer Hospital, São Paulo, Brazil., Antoniazzi A; Department of Medical Oncology, Barretos Cancer Hospital, São Paulo, Brazil.; Department of Oncogenetics / Barretos Cancer Hospital, São Paulo, Brazil., Jacinto A; Department of Radiotherapy, Barretos Cancer Hospital, São Paulo, Brazil., De Marchi P; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Department of Medical Oncology, Barretos Cancer Hospital, São Paulo, Brazil.; Department of Medical Oncology, Oncoclinicas, Rio de Janeiro, Brazil., Molina-Vila MA; Laboratory of Oncology/Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Ferro Leal L; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata, FACISB, São Paulo, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, São Paulo, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga-Guimarães, Portugal.
Publikováno v: Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2023; Vol. 90 (5), pp. 344-355. Date of Electronic Publication: 2023 Apr 08.
Zobrazit plný text záznamu
4
Akademický článek
Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.
Autor: Chiarantano RS; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Department of Diagnostic and Interventional Radiology, 67766Barretos Cancer Hospital, Barretos, Brazil., Vazquez FL; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Franco A; Barretos Municipal Health Secretary, Brazil., Ferreira LC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Cristina da Costa M; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Talarico T; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Oliveira ÂN; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Miziara JE; Department of Thoracic Surgery, Barretos Cancer Hospital, Barretos, Brazil., Mauad EC; Department of Prevention, Barretos Cancer Hospital, Barretos, Brazil., Caetano da Silva E; Department of Pathology, 67766Barretos Cancer Hospital, Barretos, Brazil., Ventura LM; Department of Diagnostic and Interventional Radiology, 67766Barretos Cancer Hospital, Barretos, Brazil., Junior RH; Department of Prevention, Barretos Cancer Hospital, Barretos, Brazil., Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; ICVS/3B's - PT Government Associate Laboratory, Guimarães, Portugal.
Publikováno v: Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2022 Jan-Dec; Vol. 29, pp. 10732748221121385.
Zobrazit plný text záznamu
5
Akademický článek
Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.
Autor: Cavagna R; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Escremim de Paula F; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil., Sant'Anna D; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Santana I; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., da Silva VD; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., da Silva ECA; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Bacchi CE; Bacchi Laboratory, Botucatu, Brazil., Miziara JE; Department of Thoracic Surgery, Barretos Cancer Hospital, Barretos, Brazil., Dias JM; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil., De Marchi P; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.; Oncoclinicas, Rio de Janeiro, Brazil., Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences, Dr Paulo Prata-FACISB, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Molecular Diagnostic Laboratory, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Publikováno v: JCO global oncology [JCO Glob Oncol] 2021 Apr; Vol. 7, pp. 639-645.
Zobrazit plný text záznamu
6
Akademický článek
EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Autor: Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, Brazil., Laus AC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Cavagna R; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Paula FE; Molecular Diagnosis Center, Barretos Cancer Hospital, Barretos, Brazil., de Oliveira MA; Department of Epidemiology and Biostatistics, Barretos Cancer Hospital, Barretos, Brazil., Ribeiro DM; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Hassan FM; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, Brazil., Miziara JE; Department of Surgery, Barretos Cancer Hospital, Barretos, Brazil., da Silva ECA; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., da Silva VD; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., De Marchi P; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, Brazil.; Oncoclinicas Group, Rio de Janeiro, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga, Portugal.
Publikováno v: Thoracic cancer [Thorac Cancer] 2020 Oct; Vol. 11 (10), pp. 2987-2992. Date of Electronic Publication: 2020 Sep 03.
Zobrazit plný text záznamu
7
Akademický článek
EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Autor: Laus AC; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela St, 1331, Barretos, SP, 14784-400, Brazil., de Paula FE; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela St, 1331, Barretos, SP, 14784-400, Brazil., de Lima MA; Epidemiology and Biostatistics Department, Barretos Cancer Hospital, Barretos, Brazil., Carlos CD; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela St, 1331, Barretos, SP, 14784-400, Brazil., Gomes INF; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela St, 1331, Barretos, SP, 14784-400, Brazil., de Marchi P; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Valente JKN; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Pioltini ABM; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Miziara JE; Surgery Department, Barretos Cancer Hospital, Barretos, Brazil., da Silva CM; Surgery Department, Barretos Cancer Hospital, Barretos, Brazil., Viana LS; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Scapulatempo-Neto C; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela St, 1331, Barretos, SP, 14784-400, Brazil. ruireis.hcb@gmail.com.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. ruireis.hcb@gmail.com.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal. ruireis.hcb@gmail.com.
Publikováno v: Molecular biology reports [Mol Biol Rep] 2019 Apr; Vol. 46 (2), pp. 2417-2425. Date of Electronic Publication: 2019 Feb 19.
Zobrazit plný text záznamu
8
Akademický článek
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.
Autor: Leal LF; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., de Paula FE; Center of Molecular Diagnoses, Barretos Cancer Hospital, Barretos, Brazil., De Marchi P; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., de Souza Viana L; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Pinto GDJ; Medical Oncology Department, Barretos Cancer Hospital, Barretos, Brazil., Carlos CD; Center of Molecular Diagnoses, Barretos Cancer Hospital, Barretos, Brazil., Berardinelli GN; Center of Molecular Diagnoses, Barretos Cancer Hospital, Barretos, Brazil., Miziara JE; Department of Thoracic surgery, Barretos, Brazil., da Silva CM; Department of Thoracic surgery, Barretos, Brazil., Silva ECA; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Pereira R; Institute of Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology at the University of Porto (IPATIMUP), Porto, Portugal., de Oliveira MA; Statistics Unity, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Scapulatempo-Neto C; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. ruireis.hcb@gmail.com.; Center of Molecular Diagnoses, Barretos Cancer Hospital, Barretos, Brazil. ruireis.hcb@gmail.com.; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal. ruireis.hcb@gmail.com.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal. ruireis.hcb@gmail.com.
Publikováno v: Scientific reports [Sci Rep] 2019 Mar 01; Vol. 9 (1), pp. 3209. Date of Electronic Publication: 2019 Mar 01.
Zobrazit plný text záznamu
9
Akademický článek
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology.
Autor: Evangelista AF; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Zanon MF; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Carloni AC; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil., de Paula FE; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Morini MA; Department of Pathology, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Ferreira-Neto M; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Soares IC; Department of Pathology, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Miziara JE; Department of Thoracic Surgery, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, CEP 14784-400, São Paulo, Brazil., de Marchi P; Department of Clinical Oncology, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, CEP 14784-400, Sao Paulo, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil.; Department of Pathology, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, CEP 14784-400, São Paulo, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, CEP 14784-400, São Paulo, Brazil. ruireis.hcb@gmail.com.; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, 4710-057, Portugal. ruireis.hcb@gmail.com.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, 4710-057, Portugal. ruireis.hcb@gmail.com.
Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2017 May 26; Vol. 17 (1), pp. 86. Date of Electronic Publication: 2017 May 26.
Zobrazit plný text záznamu
10
Akademický článek
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Autor: Paz-Ares L; Instituto de Biomedicina de Sevilla-IBIS (Hospital Virgen del Rocío/Universidad de Sevilla/CSIC), Sevilla, Spain; Hospital Universitario Doce de Octubre and CNIO Lung Cancer Unit, Madrid, Spain. Electronic address: lpazaresr@seom.org., Mezger J; St Vincentius Kliniken, Karlsruhe, Germany., Ciuleanu TE; Institute of Oncology and University of Medicine and Pharmacy, Cluj-Napoca, Romania., Fischer JR; Klinik Löwenstein GmbH, Löwenstein, Germany., von Pawel J; Asklepios-Fachkliniken Mönchen-Gauting, Gauting, Germany., Provencio M; Hospital Puerta de Hierro, Madrid, Spain., Kazarnowicz A; Samodzielny Publiczny Zespól Gruźlicy i Chorób Pluc w Olsztynie, Olsztyn, Poland., Losonczy G; Semmelweis Egyetem, Budapest, Hungary., de Castro G Jr; Instituto do Cancer do Estado de Sao Paulo (ICESP), Sao Paulo, Brazil., Szczesna A; Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy, Otwock, Poland., Crino L; Ospedale Santa Maria della Misericordia, Perugia, Italy., Reck M; LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany., Ramlau R; Poznan University of Medical Sciences, Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan, Poland., Ulsperger E; Landesklinikum Horn, NÖ, Austria., Schumann C; Department of Internal Medicine II, University Clinic Ulm, Ulm, Germany; Klinik für Pneumologie, Thoraxonkologie, Schlaf-und Beatmungsmedizin, Kempten-Oberallgäu, Germany., Miziara JE; Hospital de Câncer de Barretos, Sao Paulo, Brazil., Lessa ÁE; Hospital Santa Izabel-Santa Casa de Misericordia da Bahia, Nazare, Nazare, Brazil., Dediu M; Institute of Oncology Bucharest, Bucharest, Romania., Bálint B; Csongrád Megye Mellkasi Betegségek Szakkórháza, Deszk, Hungary., Depenbrock H; Lilly Deutschland GmbH, Bad Homburg, Germany., Soldatenkova V; Lilly Deutschland GmbH, Bad Homburg, Germany., Kurek R; Lilly Deutschland GmbH, Bad Homburg, Germany., Hirsch FR; University of Colorado, Division of Medical Oncology, Aurora, CO, USA., Thatcher N; The Christie Hospital, National Health Services Trust, Manchester, UK., Socinski MA; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2015 Mar; Vol. 16 (3), pp. 328-37. Date of Electronic Publication: 2015 Feb 18.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje